AKTX
Akari Therapeutics
AKTX
AKTX
12 hedge funds and large institutions have $3.88M invested in Akari Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HP
Hikari Power
Tokyo,
Japan
|
+$405K |
2 |
VF
Virtu Financial
New York
|
+$58K |
3 |
UBS Group
Zurich,
Switzerland
|
+$5K |
Top Sellers
1 |
BBA
Baker Bros. Advisors
New York
|
-$550K |
2 |
Millennium Management
New York
|
-$264K |
3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$33.6K |
4 |
IA
IFP Advisors
Tampa,
Florida
|
-$4K |